Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lidocaine for Pain Reduction During Infiltration Anesthesia in Tooth Extraction
NCT07707557Phase 1Active, not recruiting
- Sponsor
- Abbasi Shaheed Hospital
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by Abbasi Shaheed Hospital. Primary endpoint: Pain Intensity During Infiltration Injection Assessed by Visual Analogue Scale at 30 minutes. Started Dec 2025; status: active, not recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07707557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07707557.